Interview with Steve Kerridge, Executive Chairman, Apodi
You joined Apodi in 2008, after a hiatus from the industry following the sale of your previous company, In2Focus,…
Address: One St Peters Road, Maidenhead, Berkshire SL6 7QU, United Kingdom
Tel: 01628 500890
Established in 2008 by a group of highly experienced outsourcing business specialists, Apodi provides comprehensive outsourcing solutions to the pharmaceutical and healthcare businesses and organisations.
Apodi recognizes that the business environment for these industry sectors is changing, and that there is a need for highly professional, tailored outsourcing services offering a rapid, effective response and delivering the best ROI.
Through commercial insight, market intelligence and highly motivated people, Apodi exists to help clients achieve improved outcomes and performance.
HR Services
Resourcing Services
Healthcare Services
Teams Services
Commercialization Services
You joined Apodi in 2008, after a hiatus from the industry following the sale of your previous company, In2Focus,…
The first day of March 2013 also marked a first for GW Pharmaceuticals. On that day, the British biopharmaceutical…
When the European Medicines Agency (EMA) relocated from London to Amsterdam after the UK announced its decision to…
The signing of an agreement on the terms of a future trade relationship between Japan and the UK has been welcomed…
US Merck (MSD globally) is following through on a 2017 commitment to invest in a new early research hub in central…
Jameel Zayed of Leyton, the UK’s leading innovation funding consultancy, highlights the British pharmaceutical…
Below we highlight some recent developments in pharma and healthcare in the UK, including drug shortages in British…
The world’s two leading vaccine producers, GSK of the UK and France’s Sanofi, last week announced that they are…
With Brexit now confirmed, the UK government has been playing up the country’s scientific credentials. The aim is…
Friday January 31 2020 was officially dubbed “Brexit Day” as the UK finally left the EU, following British…
Although biotech financing in the UK took a hit last year in large part thanks to uncertainty around Brexit, 2019…
GW Pharmaceuticals reports that sales of its CBD drug Epidiolex more than doubled in the second quarter of 2019,…
Formed in 2015, listed UK start-up Amryt targets rare diseases with high unmet medical need. With one commercial…